RE:RE:RE:Some Thoughts in Summary,.,.,I dont hold any interest in xB3 at this stage,,,,nor does anyone else out there,,,,,,it has created ZERO value being expressed in share price,,,,,,it is dead technology,,,,, unless a partner releaseses positive data down the road, and I dont fear that happening. Management just never told their shareholders that!!,,,,As far as I can read between the lines xB3 will otherwise just fade away into the sunset here until such time, if ever it happens. We are most likely back to the RH days where clinic work was not on the books.
We missed all back in 2016 when BTI shares were trading at $2. Maybe at the time the business model was all licensing and cash infusion was not front row center,,,.maybe,,,,but we now see there has been a major failure in securing the future of BTI since that time. Shame!